Zhongheng Group Acquires Patent for Innovative Chronic Heart Failure Drug LZ-01
China-based Guangxi Wuzhou Zhongheng Group Co., Ltd. (SHA: 600252) announced that its wholly-owned subsidiary, Zhongheng...
SHA: 600252
Zhongheng Group and Fosun Pharmaceutical Form JV to Boost Overseas Business
China-based Zhongheng Group (SHA: 600252) has announced plans to establish a joint venture (JV) with...
Shanghai Fosun Pharmaceutical Partners with State-owned Firms to Boost ASEAN Drug Trade
Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196, HKG: 2196), a leading pharmaceutical company in...